Status:
COMPLETED
Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension
Lead Sponsor:
AstraZeneca
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of Type II DM p...
Eligibility Criteria
Inclusion
- After diagnosed type II DM, patients received treatment for a least 3 years
- Type II DM patients with hypertension and its complication.
- Visited out-patients to care center after 1 Jan. 2008
Exclusion
- Secondary hypertension patients
- Patients not receiving hypertension medication
- Patients stopping BP medication, by physician's order
- Patients currently enrolled in other clinical studies
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00771069
Start Date
November 1 2008
End Date
March 1 2009
Last Update
December 3 2010
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Wŏnju, Gangwon-do, South Korea
2
Research Site
Bucheon-si, Gyeonggi-do, South Korea
3
Research Site
Goyang-si, Gyeonggi-do, South Korea
4
Research Site
Guri-si, Gyeonggi-do, South Korea